IMMU-07. TACEDINALINE (CI994), A CLASS I HDAC INHIBITOR, TARGETS INTRINSIC TUMOR GROWTH AND LEPTOMENINGEAL DISSEMINATION IN MYC-DRIVEN MEDULLOBLASTOMA WHILE MAKING THEM SUSCEPTIBLE TO ANTI-CD47 INDUCED MACROPHAGE PHAGOCYTOSIS VIA NF-KB-TGM2 DRIVEN TUMOR INFLAMMATION

Authors: Viktoria Marquardt, Johanna Theruvath, Nan Qin, Daniel Picard, Rajeev Vibhakar, Sujatha Venkararaman, Marc Remke, Siddhartha Mitra

Published: 2023-06-12

DOI: 10.1093/neuonc/noad073.194

Source: Full article


Abstract

Abstract